Is Autologous Hematopoietic Stem Cell Transplant Better Than High-Efficacy Disease-Modifying Therapies for Relapsing Multiple Sclerosis?

Jeffrey A. Cohen, Anne H. Cross

Research output: Contribution to journal › Editorial

1 Scopus citations

Original language	English
Pages (from-to)	669-672
Number of pages	4
Journal	JAMA Neurology
Volume	80
Issue number	7
DOIs	https://doi.org/10.1001/jamaneurol.2023.0467
State	Published - Jul 10 2023

Access to Document

10.1001/jamaneurol.2023.0467

Other files and links

Link to publication in Scopus

Cite this

@article{402d78352bee468d86ef233fd68a3185,

title = "Is Autologous Hematopoietic Stem Cell Transplant Better Than High-Efficacy Disease-Modifying Therapies for Relapsing Multiple Sclerosis?",

author = "Cohen, {Jeffrey A.} and Cross, {Anne H.}",

year = "2023",

month = jul,

day = "10",

doi = "10.1001/jamaneurol.2023.0467",

language = "English",

volume = "80",

pages = "669--672",

journal = "JAMA Neurology",

issn = "2168-6149",

number = "7",

}

TY - JOUR

T1 - Is Autologous Hematopoietic Stem Cell Transplant Better Than High-Efficacy Disease-Modifying Therapies for Relapsing Multiple Sclerosis?

AU - Cohen, Jeffrey A.

AU - Cross, Anne H.

PY - 2023/7/10

Y1 - 2023/7/10

UR - http://www.scopus.com/inward/record.url?scp=85164584756&partnerID=8YFLogxK

U2 - 10.1001/jamaneurol.2023.0467

DO - 10.1001/jamaneurol.2023.0467

M3 - Editorial

C2 - 37184849

AN - SCOPUS:85164584756

SN - 2168-6149

VL - 80

SP - 669

EP - 672

JO - JAMA Neurology

JF - JAMA Neurology

IS - 7

ER -